The present invention relates to methods of treating diseases or disorders affecting the eye or optic nerve characterised by elevated β-amyloid levels or β-amyloid deposits, particularly age related macular degeneration and glaucoma type diseases and β-amyloid dependent cataract formation, with antigen binding proteins that bind β-amyloid peptide and in particular human β-amyloid peptide. [on SciFinder(R)]
CITATION STYLE
Actin Binding Proteins. (2006). In Encyclopedic Reference of Molecular Pharmacology (pp. 6–6). Springer-Verlag. https://doi.org/10.1007/3-540-29832-0_16
Mendeley helps you to discover research relevant for your work.